What is the latest price of pemetinib/pemetinib targeted drug?

Pemigatinib(Pemigatinib) is a targeted drug mainly used to treat specific types of cancer, especially malignant tumors related to fibroblast growth factor receptor (FGFR). In recent years, with the development of precision medicine, the status of pemetinib in cancer treatment has gradually increased, becoming the focus of attention of clinicians and patients.

The main indications for pemetinib include unresectable cholangiocarcinoma (CCA) and myeloid/lymphoid tumors with FGFR rearrangements. Due to its unique mechanism of action, pemetinib can effectively inhibit the FGFR signaling pathway, thereby intervening in the growth and spread of tumor cells. This has been significantly verified clinically. After using pemetinib, many patients have effectively controlled their disease and their quality of life has also been significantly improved.

In the domestic market, the launch of pemetinib has brought new treatment options, but it is not yet included in medical insurance, which directly affects patients’ medication burden. Pemetinib is mainly available in two specifications: 4.5 mg 14 tablets and 9 mg 14 tablets. The price range is roughly RMB 20,000-50,000 per box. The specific price will fluctuate due to factors such as the drug supply chain and regional differences. In addition, in overseas markets, the price of pemetinib may be higher. Taking the specification of 13.5 mg and 14 tablets as an example, the price can be as high as more than 70,000 yuan.

It is worth noting that consumers overseas can also choose to purchase generic drugs of pemetinib. The ingredients of these drugs are basically the same as those of the original drugs, which can provide patients with a more affordable option. For example, 4.5mg 14 tablets produced by Lucius Pharmaceuticals in Laos sells for only more than 700 yuan. However, due to differences in drug regulatory policies in different countries, patients need to carefully confirm the legality and quality of drugs when purchasing.

Reference materials:https://go.drugbank.com/drugs/DB15102